Fernando R Moya
Affiliation: Texas Medical Center
- A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infantsFernando R Moya
Department of Pediatrics, University of Texas Health Science Center at Houston, Houston, Texas 77030, USA
Pediatrics 115:1018-29. 2005....
- Regulation of human pulmonary surfactant protein gene expression by 1alpha,25-dihydroxyvitamin D3Sarabjit S Phokela
Dept of Pediatrics, The University of Texas Health Science Center, Houston, TX 77030, USA
Am J Physiol Lung Cell Mol Physiol 289:L617-26. 2005....
- Evidence-based management of infants with congenital diaphragmatic herniaFernando R Moya
Department of Pediatrics, Coastal Area Health Education Center, Wilmington, NC 28402 9025, USA
Semin Perinatol 29:112-7. 2005....
- Surfactant does not improve survival rate in preterm infants with congenital diaphragmatic herniaKevin P Lally
Department of Surgery, University of Texas Houston, 6431 Fannin St, MSB 5 258, Houston, TX 77030, USA
J Pediatr Surg 39:829-33. 2004..Use of exogenous surfactant in congenital diaphragmatic hernia (CDH) patients is routine in many centers. The authors sought to determine the impact of surfactant use in the premature infant with CDH...
- Postnatal dexamethasone therapy and cerebral tissue volumes in extremely low birth weight infantsNehal A Parikh
Division of Neonatal Perinatal Medicine, Department of Pediatrics, University of Texas Medical School at Houston, Houston, TX 77030, USA
Pediatrics 119:265-72. 2007..Our goal was to relate postnatal dexamethasone therapy in extremely low birth weight infants (birth weight of < or = 1000 g) to their total and regional brain volumes, as measured by volumetric MRI performed at term-equivalent age...
- Interaction of an artificial surfactant in human pulmonary epithelial cellsEdgar J Romero
Division of Neonatal Perinatal Medicine, Department of Pediatrics, University of Texas Health Science Center Houston, Houston, TX, USA
Pediatr Pulmonol 39:167-77. 2005..We conclude that while human type II cells and other lung cell types can incorporate the components of Surfaxin, the surfactant-related physiological functions of these cells are not altered...
- Randomized, controlled trial of slow versus rapid feeding volume advancement in preterm infantsJudith Caple
Department of Pediatrics, University of Texas Houston Medical School, 6431 Fannin St, MSB 3 218, Houston, Texas 77030, USA
Pediatrics 114:1597-600. 2004..We also examined whether these infants regain birth weight earlier, have fewer days of intravenous fluids, and a have shorter hospital stay...
- Longitudinal assessment of heart rate variability in very low birth weight infants during their NICU stayAsif Z Khattak
The University of Texas Medical School at Houston, Department of Pediatrics, 6431 Fannin Street, Houston, TX 77339, USA
Early Hum Dev 83:361-6. 2007..Maturation of the autonomic nervous system has not been studied in high-risk very low birth weight (VLBW) infants in the first few weeks of life...
- Risk factors predicting vasopressor use after patent ductus arteriosus ligationFurqan Moin
Department of Pediatrics, University of Texas Houston Medical School, Houston, Texas, USA
Am J Perinatol 20:313-20. 2003..Lower birth weight, lower gestational age, and higher respiratory support define a high-risk subgroup of patients in whom the prophylactic administration of vasopressor(s) could be studied...
- Surfactant trialsFernando R Moya
Pediatrics 117:245-7; author reply 247-8. 2006
- Surfactant replacement therapy on ECMO does not improve outcome in neonates with congenital diaphragmatic herniaChristopher E Colby
Division of Neonatal and Developmental Medicine, Stanford University, Palo Alto, CA 94304, USA
J Pediatr Surg 39:1632-7. 2004..The aim of this study was to determine if surfactant replacement on extracorporeal membrane oxygenation (ECMO) results in improved outcomes in neonates > or =35 weeks' gestation with unrepaired CDH...